Startups
In November 2011 Dom Raban (one of the Xploro® founders) received the tragic news that his 13 year old daughter had been diagnosed with Ewing’s Sarcoma, a rare bone cancer.
She's now 7 years cancer-free but when she was ill she received virtually no prior information about the people she would meet, the environments she would be treated in or the technology and processes that would be used to treat her. That lack of information left her feeling scared anxious and alone. She was resistant to treatments because their purpose wasn’t explained to her and she was scared to go in to hospital because she didn’t know what to expect.
And so in response to his daughter’s experience, and the experiences of other patients about to go undergo unfamiliar and scary medical treatments, Dom and his team are developing Xploro®.
Xploro® is a mobile application that uses augmented reality, gameplay and artificial intelligence to deliver health information to patients, reducing the stress and anxiety associated with hospitalisation, improving health literacy and fostering better engagement with health services.
We’re starting with children with cancer, but we’re aiming to build a health information platform for any patient, of any age, with any condition, anywhere in the world.
She's now 7 years cancer-free but when she was ill she received virtually no prior information about the people she would meet, the environments she would be treated in or the technology and processes that would be used to treat her. That lack of information left her feeling scared anxious and alone. She was resistant to treatments because their purpose wasn’t explained to her and she was scared to go in to hospital because she didn’t know what to expect.
And so in response to his daughter’s experience, and the experiences of other patients about to go undergo unfamiliar and scary medical treatments, Dom and his team are developing Xploro®.
Xploro® is a mobile application that uses augmented reality, gameplay and artificial intelligence to deliver health information to patients, reducing the stress and anxiety associated with hospitalisation, improving health literacy and fostering better engagement with health services.
We’re starting with children with cancer, but we’re aiming to build a health information platform for any patient, of any age, with any condition, anywhere in the world.
Overview
Location
United Kingdom, England, Manchester
Employees
11-50
Total raised
$1.7M
Founded date
2019
Investors 6
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| o2h ventures | o2hventures.com | |
| May 7, 2025 | GC Angels | gcangels.uk |
| Mar 21, 2022 | Plug and Play Tech Center | plugandplaytechcenter.com |
| KidsX | kidsx.health | |
| Oct 4, 2024 | North Coast Ventures | northcoast.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 11, 2024 | Leo Cancer Care Enters Unique Collaboration With Innovative Child-Patient App | Helping make the cancer treatment journey less daunting for patients of all ages. MIDDLETON, WISCONSIN, UNITED STATES, January 11, 2024 /EINPresswire.com/ -- Leo Cancer Care is teaming up with the producers of an innovative app designed to ... |
| Dec 22, 2023 | Boomerang Ventures talks investing in pediatric health education startup Xploro | Xploro uses AR, gaming, and AI to offer health information, to engage and inform young patients Pediatrics is a space that doesn't see much venture funding: in the first three quarters of 2023, digital health startups addressing pediatric h... |
| Dec 21, 2023 | Boomerang Ventures Leads $1.7 Million Series Seed Round for Pediatric Digital Health Startup Xploro | Boomerang Ventures, a leading venture capital and studio firm, has strategically invested in Xploro a pioneer in pediatric digital health. Leading the $1.7M Series Seed round, Boomerang Ventures underscores its dedication to fostering innov... |
| Dec 20, 2023 | Xploro Raises 1.7M in Seed Funding | Xploro Inc., a Cleveland, Ohio-based pediatric digital health company, raised $1.7M in Seed funding. Boomerang Ventures invested in the round. The company intends to use the funds to expand into new treatment areas, enhance sales and custom... |
| Dec 20, 2023 | Xploro Snares $1.7M Seed Round | CLEVELAND, OH, Xploro Inc., a pioneer in pediatric digital health, has raised a $1.7M Series Seed round of funding led by Boomerang Ventures. >> Click here for more funding data on Xploro >> To export Xploro funding data to ... |
| Oct 27, 2023 | Meet October Pitch Presenter Dom Raban of Xploro: Replacing Young Patients’ Fear with Empowerment | You’re probably wondering who the funny avatar startup founder is and why he doesn’t have a “real” head shot. That guy is Dom Raban, the founder and CEO of Xploro, an international award-winning startup that removes the fear and anxiety kid... |
| Apr 5, 2019 | 5th Annual AXA Health Tech & You Awards finalists announced | 5th Annual AXA Health Tech & You Awards finalists announced 05-04-2019 Entrepreneurs and innovators from all over the world are recognised in the fifth year of the Health Tech & You Awards programme. Finalists from the fifth annual ... |
| Xploro | “Empowering young patients with information” |
Reviews 0
FAQ about Xploro®
When was Xploro® founded?
Xploro® was founded in 2019.
How much funding has Xploro® raised?
Xploro® has raised $1.7M in total across 1 funding round.
Who has invested in Xploro®?
Parsers VC lists 6 investors of Xploro®, among them GC Angels, North Coast Ventures and Plug and Play Tech Center.
What has the press written about Xploro®?
Parsers VC has collected 9 articles mentioning Xploro®, among them “Leo Cancer Care Enters Unique Collaboration With Innovative Child-Patient App” (Jan 11, 2024) and “Boomerang Ventures talks investing in pediatric health education startup Xploro” (Dec 22, 2023).
Is Xploro® still active?
Yes, Xploro® is active; its latest activity on Parsers VC dates from Jul 3, 2025.